134 related articles for article (PubMed ID: 12469798)
1. Remodelling of zero-stress state of small intestine in streptozotocin-induced diabetic rats. Effect of gliclazide.
Zhao J; Sha H; Zhou S; Tong X; Zhuang FY; Gregersen H
Dig Liver Dis; 2002 Oct; 34(10):707-16. PubMed ID: 12469798
[TBL] [Abstract][Full Text] [Related]
2. Effect of Kaiyu Qingwei Jianji on the morphometry and residual strain distribution of small intestine in experimental diabetic rats.
Sha H; Zhao JB; Zhang ZY; Zhou SP; Tong XL; Zhuang FY; Gregersen H
World J Gastroenterol; 2006 Nov; 12(44):7149-54. PubMed ID: 17131477
[TBL] [Abstract][Full Text] [Related]
3. Effect of tangweian jianji on upper gastrointestinal remodeling in streptozotocin-induced diabetic rats.
Liu GF; Zhao JB; Zhen Z; Sha H; Chen PM; Li M; Zhang JC; Yuan MZ; Gao W; Gregersen H; Tong XL
World J Gastroenterol; 2012 Sep; 18(35):4875-84. PubMed ID: 23002359
[TBL] [Abstract][Full Text] [Related]
4. Biomechanical and morphometric intestinal remodelling during experimental diabetes in rats.
Zhao J; Yang J; Gregersen H
Diabetologia; 2003 Dec; 46(12):1688-97. PubMed ID: 14593459
[TBL] [Abstract][Full Text] [Related]
5. Morphological properties and residual strain along the small intestine in rats.
Zhao JB; Sha H; Zhuang FY; Gregersen H
World J Gastroenterol; 2002 Apr; 8(2):312-7. PubMed ID: 11925615
[TBL] [Abstract][Full Text] [Related]
6. The morphometry and biomechanical properties of the rat small intestine after systemic treatment with epidermal growth factor.
Zhao J; Yang J; Vinter-Jensen L; Zhuang F; Gregersen H
Biorheology; 2002; 39(6):719-33. PubMed ID: 12454438
[TBL] [Abstract][Full Text] [Related]
7. Viscoelastic behavior of small intestine in streptozotocin-induced diabetic rats.
Zhao J; Liao D; Yang J; Gregersen H
Dig Dis Sci; 2003 Dec; 48(12):2271-7. PubMed ID: 14714612
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the anti-diabetic effects of resveratrol, gliclazide and losartan in streptozotocin-induced experimental diabetes.
Yazgan ÜC; Taşdemir E; Bilgin HM; Deniz Obay B; Şermet A; Elbey B
Arch Physiol Biochem; 2015; 121(4):157-61. PubMed ID: 26161595
[TBL] [Abstract][Full Text] [Related]
9. Effect of insulin and gliclazide on glucose utilization by a perfused intestine-pancreas preparation isolated from diabetic and non-diabetic rats.
Tormo MA; Gomez-Zubeldia MA; Ropero F; Campillo JE
Acta Diabetol; 1994 Sep; 31(3):151-5. PubMed ID: 7827354
[TBL] [Abstract][Full Text] [Related]
10. Effect of I-deprenyl and gliclazide on oxidant stress/antioxidant status and dna damage in a diabetic rat model.
Alper G; Irer S; Duman E; Caglayan O; Yilmaz C
Endocr Res; 2005; 31(3):199-212. PubMed ID: 16392622
[TBL] [Abstract][Full Text] [Related]
11. Comparison of beta-cell function after long-term treatment with either insulin, insulin plus gliclazide or gliclazide in neonatal streptozotocin-induced non-insulin-dependent diabetic rats.
Kawai K; Suzuki S; Murayama Y; Watanabe Y; Yamashita K
Diabetes Res Clin Pract; 1991 Jul; 12(3):163-72. PubMed ID: 1832376
[TBL] [Abstract][Full Text] [Related]
12. Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats.
Mahfoz AM; El-Latif HA; Ahmed LA; Hassanein NM; Shoka AA
Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1315-1324. PubMed ID: 27612855
[TBL] [Abstract][Full Text] [Related]
13. Biomechanical and histomorphometric colon remodelling in STZ-induced diabetic rats.
Zhao J; Nakaguchi T; Gregersen H
Dig Dis Sci; 2009 Aug; 54(8):1636-42. PubMed ID: 18989775
[TBL] [Abstract][Full Text] [Related]
14. Tension-strain relations and morphometry of rat small intestine in experimental diabetes.
Jørgensen CS; Ahrensberg JM; Gregersen H; Flyvberg A
Dig Dis Sci; 2001 May; 46(5):960-7. PubMed ID: 11341665
[TBL] [Abstract][Full Text] [Related]
15. Gliclazide treatment of streptozotocin diabetic rats restores GLUT4 protein content and basal glucose uptake in skeletal muscle.
Pulido N; Suarez A; Casanova B; Romero R; Rodriguez E; Rovira A
Metabolism; 1997 Dec; 46(12 Suppl 1):10-3. PubMed ID: 9439552
[TBL] [Abstract][Full Text] [Related]
16. Biomechanical and morphometric properties of the arterial wall referenced to the zero-stress state in experimental diabetes.
Zhao J; Lu X; Zhuang F; Gregersen H
Biorheology; 2000; 37(5-6):385-400. PubMed ID: 11204544
[TBL] [Abstract][Full Text] [Related]
17. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.
Portha B; Serradas P
Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320
[TBL] [Abstract][Full Text] [Related]
18. Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin.
Serradas P; Bailbé D; Portha B
Diabetologia; 1989 Aug; 32(8):577-84. PubMed ID: 2528491
[TBL] [Abstract][Full Text] [Related]
19. Involvement of glucose-regulated protein 78 and spliced X-box binding protein 1 in the protective effect of gliclazide in diabetic nephropathy.
Zhang YW; Wang X; Ren X; Zhang M
Diabetes Res Clin Pract; 2018 Dec; 146():41-47. PubMed ID: 28951332
[TBL] [Abstract][Full Text] [Related]
20. Gliclazide inhibits diabetic neuropathy irrespective of blood glucose levels in streptozotocin-induced diabetic rats.
Qiang X; Satoh J; Sagara M; Fukuzawa M; Masuda T; Miyaguchi S; Takahashi K; Toyota T
Metabolism; 1998 Aug; 47(8):977-81. PubMed ID: 9711995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
